Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Ltd

₹ 557 1.41%
19 Jun - close price
About

Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.

Key Points

Business Segment:
a) Hospitals & Clinics Portfolio[1]
Jeena Sikho Lifecare Limited (JSLL) operates a network of 36 hospitals and 74 clinics/daycare centres across 21 states and 100+ cities in India. The hospitals have 2300 operational beds, with another 1000 beds in the pipeline.

  • Market Cap 6,926 Cr.
  • Current Price 557
  • High / Low 850 / 415
  • Stock P/E 31.2
  • Book Value 37.6
  • Dividend Yield 0.20 %
  • ROCE 64.1 %
  • ROE 61.3 %
  • Face Value 2.00

Pros

  • Debtor days have improved from 49.0 to 31.8 days.

Cons

  • Stock is trading at 14.8 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
114 116 139 174 190 222 216
74 86 93 96 98 121 138
Operating Profit 40 30 46 79 92 101 78
OPM % 35% 26% 33% 45% 48% 45% 36%
3 0 0 1 1 3 3
Interest 2 4 3 2 4 3 4
Depreciation 6 8 9 10 10 11 16
Profit before tax 35 18 34 69 79 89 61
Tax % 25% 26% 25% 25% 25% 25% 26%
27 13 25 51 59 67 45
EPS in Rs 2.14 1.06 2.04 4.12 4.73 5.36 3.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2025 Mar 2026
147 205 469 801
128 159 328 452
Operating Profit 18 46 141 349
OPM % 12% 22% 30% 44%
1 3 7 8
Interest 1 1 11 13
Depreciation 3 3 29 48
Profit before tax 15 44 108 297
Tax % 26% 24% 26% 25%
11 34 80 222
EPS in Rs 1.23 2.72 6.43 17.85
Dividend Payout % 0% 8% 0% 25%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 58%
TTM: 71%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 88%
TTM: 178%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 121%
1 Year: 31%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 61%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2025 Mar 2026
Equity Capital 10 14 25 25
Reserves 26 112 231 442
7 1 117 127
18 24 46 80
Total Liabilities 62 151 419 674
29 60 255 294
CWIP 5 1 11 2
Investments 0 5 4 110
28 86 149 269
Total Assets 62 151 419 674

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2025 Mar 2026
16 15 84 254
-18 -33 -64 -202
-5 48 -22 -59
Net Cash Flow -7 29 -2 -7
Free Cash Flow -2 -15 45 221
CFO/OP 112% 50% 84% 94%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2025 Mar 2026
Debtor Days 23 39 66 32
Inventory Days 149 85 78 81
Days Payable 109 126 106 92
Cash Conversion Cycle 62 -1 38 20
Working Capital Days -12 28 30 58
ROCE % 52% 64%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
IPD Patient Volumes
Number of Patients

Log in to view insights

Please log in to see hidden values.

Login
OPD Patient Volumes
Lakhs
Operational Bed Capacity
Number of Beds
Total Operational Units (Hospitals, Clinics & Day Care)
Number
Average Revenue Per Bed
INR
Ayurveda Medicine SKU Portfolio
Number (SKUs)
Number of Operational Hospitals
Number
Bed Occupancy Rate
%
Video-call Consultations
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

18 Recently
Apr 2022Sep 2022Mar 2023Sep 2023Nov 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
65.89% 65.89% 66.20% 67.91% 67.91% 67.91% 65.84% 63.53% 63.53% 63.61% 63.62% 63.62%
0.00% 0.00% 0.00% 2.00% 1.79% 0.26% 4.05% 5.95% 5.91% 6.59% 6.31% 6.17%
0.00% 0.00% 0.00% 0.04% 0.00% 0.00% 0.07% 0.17% 0.18% 0.15% 0.11% 0.46%
34.11% 34.11% 33.80% 30.05% 30.30% 31.83% 30.04% 30.34% 30.38% 29.65% 29.97% 29.77%
No. of Shareholders 1,9518346638151,1072,7213,4235,9676,60316,36222,18125,905

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls